Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors

NCT05270213 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

164

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Cancer

Interventions

DRUG: RBS2418
DRUG: Pembrolizumab
DRUG: Other approved anti-cancer therapy

Sponsor

Riboscience, LLC.